Cellpeutics
Cellpeutics is a specialised antibody development division of T-Cure Bioscience focused on developing research antibodies for major allergens, difficult proteins, and underserved research targets.
T-Cure Bioscience is a clinical-stage cell and gene therapy company developing the next generation of T cell therapies against solid tumours.
Allergen Antibodies
Art v 1
Major Mugwort Allergen Polyclonal Antibody
Mouse polyclonal serum targeting Art v 1, a major allergen associated with Artemisia species.

Western blot with recombinant target protein. Figure reproduced from the product data sheet.
Der p 2
House Dust Mite Allergen Polyclonal Antibody
Mouse polyclonal antibody targeting Der p 2, a major allergen of Dermatophagoides pteronyssinus (house dust mite).

Western blot with recombinant target protein. Figure reproduced from the product data sheet.
Cellpeutics' allergen antibody portfolio continues to expand, with additional research antibodies currently in development against major environmental allergen targets.
Specialised Antibody Development
Beyond their current portfolio, Cellpeutics works with researchers and laboratories seeking antibodies against specific or challenging targets, particularly for targets where reliable commercial antibodies are limited or unavailable.
If there is an antibody you would like to see developed, we invite you to discuss the target and your research requirements with us!

